Nasturtium (Tropaeolum Majus L) Intake and Biochemical Parameters in Pre-diabetic Subjects in Bogota Colombia

Plain-language summary

This study examines the effect of consuming nasturtium (Tropaeolum majus) on biochemical parameters in pre-diabetic individuals, comparing it with a placebo. It enrolled patients aged 25-60 with a body mass index above 30 who had been diagnosed with glucose intolerance for at least six months. This is a study without a phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Completed

Sponsor

Javeriana University

Intervention

Nasturtium (Tropaeolum majus), Placebo

Start date

6/1/2018

Estimated completion

11/15/2021

Countries

Colombia

Related genes

Locations

• Bogotá, Colombia

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Patients aged 25-60 years, with a clinical diagnosis of glucose intolerance for at least six months.
* Body mass index (BMI) \> 30 kg/m2. The BMI will be restricted to \> 30 kg/m2 to reduce the variability in the lipid profile parameters, which frequently are normal in subject with normal BMI.
* Sign informed consent

Exclusion Criteria:

* Severe impairment of cardiac, hepatic or renal function.
* Gestation or lactation
* Use of insulin injection
* Pharmacotherapy with metformin or iDPP4, which alter insulin sensitivity or Glycaemia
* Consumption of antioxidant or vitamin supplements
* Consumption of estrogen or vitamin K-antagonists